298 related articles for article (PubMed ID: 33479603)
1. Broad-spectrum antitumor properties of Withaferin A: a proteomic perspective.
Dom M; Vanden Berghe W; Van Ostade X
RSC Med Chem; 2020 Jan; 11(1):30-50. PubMed ID: 33479603
[TBL] [Abstract][Full Text] [Related]
2. Proteomic characterization of Withaferin A-targeted protein networks for the treatment of monoclonal myeloma gammopathies.
Dom M; Offner F; Vanden Berghe W; Van Ostade X
J Proteomics; 2018 May; 179():17-29. PubMed ID: 29448055
[TBL] [Abstract][Full Text] [Related]
3. SILAC-based quantitative MS approach reveals Withaferin A regulated proteins in prostate cancer.
Kumar R; Nayak D; Somasekharan SP
J Proteomics; 2021 Sep; 247():104334. PubMed ID: 34298187
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of the NEMO/IKKβ association complex formation, a novel mechanism associated with the NF-κB activation suppression by Withania somnifera's key metabolite withaferin A.
Grover A; Shandilya A; Punetha A; Bisaria VS; Sundar D
BMC Genomics; 2010 Dec; 11 Suppl 4(Suppl 4):S25. PubMed ID: 21143809
[TBL] [Abstract][Full Text] [Related]
5. Withaferin A inhibits the proteasome activity in mesothelioma in vitro and in vivo.
Yang H; Wang Y; Cheryan VT; Wu W; Cui CQ; Polin LA; Pass HI; Dou QP; Rishi AK; Wali A
PLoS One; 2012; 7(8):e41214. PubMed ID: 22912669
[TBL] [Abstract][Full Text] [Related]
6. Identification and quantitative analysis of cellular proteins affected by treatment with withaferin a using a SILAC-based proteomics approach.
Narayan M; Seeley KW; Jinwal UK
J Ethnopharmacol; 2015 Dec; 175():86-92. PubMed ID: 26392330
[TBL] [Abstract][Full Text] [Related]
7. Overview of the anticancer activity of withaferin A, an active constituent of the Indian ginseng Withania somnifera.
Sivasankarapillai VS; Madhu Kumar Nair R; Rahdar A; Bungau S; Zaha DC; Aleya L; Tit DM
Environ Sci Pollut Res Int; 2020 Jul; 27(21):26025-26035. PubMed ID: 32405942
[TBL] [Abstract][Full Text] [Related]
8. Growth arrest by the antitumor steroidal lactone withaferin A in human breast cancer cells is associated with down-regulation and covalent binding at cysteine 303 of β-tubulin.
Antony ML; Lee J; Hahm ER; Kim SH; Marcus AI; Kumari V; Ji X; Yang Z; Vowell CL; Wipf P; Uechi GT; Yates NA; Romero G; Sarkar SN; Singh SV
J Biol Chem; 2014 Jan; 289(3):1852-65. PubMed ID: 24297176
[TBL] [Abstract][Full Text] [Related]
9. The Role of Forkhead Box Q1 Transcription Factor in Anticancer Effects of Withaferin A in Breast Cancer.
Kim SH; Singh KB; Hahm ER; Singh SV
Cancer Prev Res (Phila); 2021 Apr; 14(4):421-432. PubMed ID: 33509807
[TBL] [Abstract][Full Text] [Related]
10. Withaferin A induces apoptosis by ROS-dependent mitochondrial dysfunction in human colorectal cancer cells.
Xia S; Miao Y; Liu S
Biochem Biophys Res Commun; 2018 Sep; 503(4):2363-2369. PubMed ID: 29966656
[TBL] [Abstract][Full Text] [Related]
11. Withaferin A: From Ancient Remedy to Potential Drug Candidate.
Sultana T; Okla MK; Ahmed M; Akhtar N; Al-Hashimi A; Abdelgawad H; Haq IU
Molecules; 2021 Dec; 26(24):. PubMed ID: 34946778
[TBL] [Abstract][Full Text] [Related]
12. Withaferin A triggers G2/M arrest and intrinsic apoptosis in glioblastoma cells via ATF4-ATF3-CHOP axis.
Tang Q; Ren L; Liu J; Li W; Zheng X; Wang J; Du G
Cell Prolif; 2020 Jan; 53(1):e12706. PubMed ID: 31642559
[TBL] [Abstract][Full Text] [Related]
13. Tackling Chronic Inflammation with Withanolide Phytochemicals-A Withaferin a Perspective.
Logie E; Vanden Berghe W
Antioxidants (Basel); 2020 Nov; 9(11):. PubMed ID: 33182809
[TBL] [Abstract][Full Text] [Related]
14. Withaferin A targets heat shock protein 90 in pancreatic cancer cells.
Yu Y; Hamza A; Zhang T; Gu M; Zou P; Newman B; Li Y; Gunatilaka AA; Zhan CG; Sun D
Biochem Pharmacol; 2010 Feb; 79(4):542-51. PubMed ID: 19769945
[TBL] [Abstract][Full Text] [Related]
15. Withaferin A-induced apoptosis in human breast cancer cells is mediated by reactive oxygen species.
Hahm ER; Moura MB; Kelley EE; Van Houten B; Shiva S; Singh SV
PLoS One; 2011; 6(8):e23354. PubMed ID: 21853114
[TBL] [Abstract][Full Text] [Related]
16. Molecular targets and mechanisms of cancer prevention and treatment by withaferin a, a naturally occurring steroidal lactone.
Vyas AR; Singh SV
AAPS J; 2014 Jan; 16(1):1-10. PubMed ID: 24046237
[TBL] [Abstract][Full Text] [Related]
17. Withaferin A induces heme oxygenase (HO-1) expression in endothelial cells via activation of the Keap1/Nrf2 pathway.
Heyninck K; Sabbe L; Chirumamilla CS; Szarc Vel Szic K; Vander Veken P; Lemmens KJA; Lahtela-Kakkonen M; Naulaerts S; Op de Beeck K; Laukens K; Van Camp G; Weseler AR; Bast A; Haenen GRMM; Haegeman G; Vanden Berghe W
Biochem Pharmacol; 2016 Jun; 109():48-61. PubMed ID: 27045103
[TBL] [Abstract][Full Text] [Related]
18. Exploring the Multifaceted Therapeutic Potential of Withaferin A and Its Derivatives.
Behl T; Sharma A; Sharma L; Sehgal A; Zengin G; Brata R; Fratila O; Bungau S
Biomedicines; 2020 Dec; 8(12):. PubMed ID: 33291236
[TBL] [Abstract][Full Text] [Related]
19. Hsp90/Cdc37 chaperone/co-chaperone complex, a novel junction anticancer target elucidated by the mode of action of herbal drug Withaferin A.
Grover A; Shandilya A; Agrawal V; Pratik P; Bhasme D; Bisaria VS; Sundar D
BMC Bioinformatics; 2011 Feb; 12 Suppl 1(Suppl 1):S30. PubMed ID: 21342561
[TBL] [Abstract][Full Text] [Related]
20. A Comprehensive Review and Perspective on Anticancer Mechanisms of Withaferin A in Breast Cancer.
Hahm ER; Kim SH; Singh KB; Singh K; Singh SV
Cancer Prev Res (Phila); 2020 Sep; 13(9):721-734. PubMed ID: 32727824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]